About
ANGION is a biotechnology company focused on developing lymph node-targeted immunotherapies to amplify immune responses against solid tumors, particularly in cancer treatment.
Explore ANGION's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.